Filter
1819
Filtered Results: 1819
Text search:
intellectual
property
Featured
Recommendations
224
New Publications
393
Language
Document type
No document type
708
Studies & Reports
377
Guidelines
337
Manuals
194
Strategic & Response Plan
113
Training Material
47
Fact sheets
29
Situation Updates
7
Resource Platforms
5
Infographics
2
Countries / Regions
Global
148
India
35
Africa
28
Kenya
27
South–East Asia Region
27
Western and Central Europe
27
Ukraine
26
Uganda
24
South Africa
23
Nepal
20
Ethiopia
20
Ghana
18
Nigeria
15
Eastern Europe and Central Asia
15
Asia
14
West and Central Africa
14
East and Southern Africa
14
Myanmar / Burma
13
Sierra Leone
12
Malawi
12
Bangladesh
12
Zambia
12
Rwanda
11
Syria
11
Middle East and North Africa
11
Indonesia
11
Cambodia
10
Liberia
10
Tanzania
9
Yemen
8
Lesotho
7
Afghanistan
7
Western Pacific Region
7
Eastern Europe
7
South Sudan
7
Latin America and the Carribbean
6
Cameroon
5
Zimbabwe
5
Philippines
5
Guinea
5
Mozambique
5
Congo, Democratic Republic of
5
Somalia
5
Pakistan
5
Thailand
4
Haiti
4
Germany
4
Vietnam
4
Russia
4
Sudan
4
North Macedonia
3
Tajikistan
3
Kazakhstan
3
Iran
3
Laos
3
Burkina Faso
3
Jordan
3
Lebanon
3
Colombia
2
China
2
Chile
2
Kyrgyzstan
2
Peru
2
Venezuela
2
Lithuania
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Djibouti
2
Palestine
2
Georgia
2
Angola
2
Botswana
2
Iraq
2
Ecuador
2
Timor Leste/ East Timor
1
Mexico
1
Serbia
1
Turkey
1
Benin
1
Albania
1
Canada
1
Senegal
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Paraguay
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Sri Lanka
1
Namibia
1
Egypt
1
Greece
1
Central African Republic
1
Mali
1
Chad
1
Libya
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
375
Clinical Guidelines
222
Public Health
161
Women & Child Health
134
Key Resources
132
Capacity Building
56
Pharmacy & Technologies
42
Toolboxes
Mental Health
189
Disability
151
HIV
143
COVID-19
136
TB
90
NTDs
86
Planetary Health
82
Caregiver
81
Rapid Response
67
AMR
63
Global Health Education
54
NCDs
43
Pharmacy
42
Conflict
42
Health Financing Toolbox
32
Refugee
20
Ebola & Marburg
17
Social Ethics
13
Natural Hazards
11
Specific Hazards
9
Polio
6
Cholera
3
Malaria
3
Zika
3
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term...
This guide is designed to accompany the training module, Communicating with health workers about COVID-19 vaccination. It provides detailed explanations, resources and guidance to accompany the slides in the training module and support those implementing the training. It is intended for training fac...
The following technical report outlines the rationale, process and results of a joint research study, coordinated by the World Health Organization (WHO) and the Pan-American Health Organization (PAHO), co-chaired by the Ministry of Health and Social Protection and the Ministry of Environment and Sus...
This concept note describes the methods used to assess the prevalence of any HIVDR and HIVDR by PMTCT exposure among children less than 18 months of age using remnant dried blood spot specimens from early infant diagnosis over a 12-month period
Guidance
Second Edition
Monitoring and Evaluation
В настоящем документе представлен первоначальный обзор поступающей информации
(по состоянию на 2 июля 2020 г.) о взаимосвязи между COVID-19, НИЗ и факторами
риска НИЗ. Ре...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
recommended
Guidance has been updated on a number of chemicals: asbestos, bentazone, chromium, iodine, manganese, microcystins, nickel, silver, tetrachloroethene and trichloroethene. Guidance has also been added for chemicals not previously assessed in the Guidelines: anatoxin-a and analogues, cylindrospermopsi...
Toolkit
HIV Treatment and Care
Implementation guide for national, district and facility levels.
This implementation guide contains practical guidance for policy-makers,
programme managers, health practitioners and other actors working to
establish and implement quality of care (QoC) programmes for maternal,
newborn and child ...
A two-week mission was conducted by WASH and quality UHC technical experts from WHO headquarters and supported by the WHO Ethiopia Country Office (WASH and health systems teams) in July 2016, to understand how change in WASH services and quality improvements have been implemented in Ethiopia at nati...
Guidelines
June 2017
HIV strategic information for impact
The Country Cooperation Strategy (CCS) is a document to guide WHO’s work in countries. CCS is a medium-term vision for WHO’s technical cooperation with a given Member State, and supports the country's national health policy, strategy or plan. The CCS time frame is flexible to align with national...
Monitoring is a crucial element in any successful programme. It is important to
know if health care facilities – and ultimately countries – are meeting the agreed
goals and objectives for preventing and managing cardiovascular diseases (CVD).
Monitoring is the on-going collection, management ...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
